![](https://investorshub.advfn.com/uicon/539856.png?cb=1492977216)
Tuesday, March 28, 2017 7:59:40 AM
Dfcon.com
There is a stickie that mentions an acquaintance who attended. Otiko was in a room with about 20 other abstract poster presenters. He offered product samples to interested persons. He was not a speaker.
The product Otiko used in his abstract is available from at least one other competitor business under a different brand name. In a nearly identical formulation, Diabecline won an award in 2012 (see ibox table comparing Diabecline and Viabecline).
The underlying transdermal delivery system is patent-pending (Phillips/Keough). Otiko has a non-exclusive license to market and distribute Viabecline which is based on this system.
Read the last filing carefully to better understand this company. The Annual Report is due this week.
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM